12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements during Thursday's intraday session. Precigen, Science 37 Hldgs, Repare Therapeutics, Macrogenics, Atara Biotherapeutics, and LifeMD saw their stocks rise by 19.18% to 25.0%. On the other hand, Galera Therapeutics, Matinas BioPharma Hldgs, Surrozen, X4 Pharmaceuticals, Virios Therapeutics, and Strata Skin Sciences saw their stocks fall by 23.87% to 83.9%. These movements were largely driven by the release of Q2 earnings reports.
August 10, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Atara Biotherapeutics' stock rose 21.01% following the release of its Q2 earnings report.
The release of Atara Biotherapeutics' Q2 earnings report likely drove the significant increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
LifeMD's stock rose 19.18% following the release of its Q2 earnings report.
The release of LifeMD's Q2 earnings report likely drove the significant increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Macrogenics' stock increased by 21.08% following the release of its Q2 earnings report.
The release of Macrogenics' Q2 earnings report likely drove the significant increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Precigen's stock rose 25.0% following the release of its Q2 earnings report.
The release of Precigen's Q2 earnings report likely drove the significant increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Repare Therapeutics' stock moved upwards by 22.68% following the release of its Q2 earnings report.
The release of Repare Therapeutics' Q2 earnings report likely drove the significant increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Science 37 Hldgs' stock increased by 24.95% following the release of its Q2 earnings report.
The release of Science 37 Hldgs' Q2 earnings report likely drove the significant increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Galera Therapeutics' stock fell 83.9% during Thursday's session.
The significant decrease in Galera Therapeutics' stock price may be due to negative market sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Matinas BioPharma Hldgs' stock declined by 48.49% following the release of its Q2 earnings report.
The release of Matinas BioPharma Hldgs' Q2 earnings report likely drove the significant decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Surrozen's stock declined by 35.79% following the release of its Q2 earnings report.
The release of Surrozen's Q2 earnings report likely drove the significant decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Strata Skin Sciences' stock fell 23.87% following the release of its Q2 earnings report.
The release of Strata Skin Sciences' Q2 earnings report likely drove the significant decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Virios Therapeutics' stock fell 33.12% following the release of its Q2 earnings report.
The release of Virios Therapeutics' Q2 earnings report likely drove the significant decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
X4 Pharmaceuticals' stock fell 33.24% following the release of its Q2 earnings report.
The release of X4 Pharmaceuticals' Q2 earnings report likely drove the significant decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100